Zivo Bioscience, Inc.
ZIVO
$6.96
-$2.54-26.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.49M | -9.72M | -16.32M | -13.38M | -13.69M |
| Total Depreciation and Amortization | 98.30K | 98.30K | 98.30K | 98.30K | 91.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 4.90K |
| Total Other Non-Cash Items | 4.44M | 5.42M | 12.46M | 9.47M | 8.82M |
| Change in Net Operating Assets | 864.70K | 303.10K | -285.90K | -500.50K | 655.80K |
| Cash from Operations | -3.08M | -3.90M | -4.04M | -4.31M | -4.12M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 738.20K | 488.20K | 488.20K | 517.60K | 667.60K |
| Total Debt Repaid | -580.90K | -572.40K | -563.90K | -538.20K | -1.69M |
| Issuance of Common Stock | 2.82M | 3.99M | 4.50M | 5.60M | 3.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.98M | 3.90M | 4.42M | 5.58M | 2.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.30K | 7.20K | 378.40K | 1.27M | -1.33M |